Search results
Oppenheimer raises IAC shares target by $10 By Investing.com
Investing.com· 4 days agoOn Thursday, Oppenheimer adjusted its outlook on IAC/InterActiveCorp (NASDAQ:IAC), increasing the...
Stock prices are now at 'more attractive levels' - Oppenheimer By Investing.com
Investing.com· 7 days agoOppenheimer analysts said in a note Monday that better-than-expected Q1 S&P 500 earnings and the...
MTV Cancels Movie and TV Awards for 2024, Skips "Barbenheimer" Movies After 2023 Ratings Debacle -...
Showbiz411· 6 hours agoMTV will not have a 2024 Movie and TV Awards this year. You may recall that last year’s show was a...
FINRA enforcement roundup: Three firms fined for trade compliance lapses
Compliance Week· 4 days agoLaw School in Manhattan, New York. The event agenda includes 40+ speakers, including representatives...
ARAMARK shares target raised by Oppenheimer on strong Q2 performance By Investing.com
Investing.com· 3 days agoOn Wednesday, Oppenheimer adjusted its outlook on ARAMARK Holdings (NYSE:ARMK) shares, increasing...
John Krasinski Reveals His Daughters Handle Mother’s Day for His Wife Emily Blunt: ‘The Kids Run the...
People via Yahoo News· 2 days ago‘The Office’ alum and ‘Oppenheimer’ star are parents to daughters Hazel, 10, and Violet, 7 Frazer...
WillScot Mobile Mini stock gets Outperform from Oppenheimer on revised financial projections By...
Investing.com· 7 days agoOn Monday, Oppenheimer adjusted its price target on WillScot (NASDAQ:WSC) Mobile Mini...
ULTA Salon share price target cut as Oppenheimer sees negative guidance revision By Investing.com
Investing.com· 6 days agoOn Tuesday, Oppenheimer adjusted its price target for ULTA Salon (NASDAQ: ULTA), shares reducing it...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 4 days agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
Relay Therapeutics shares target cut by Oppenheimer, bullish on drug candidate prospects By...
Investing.com· 7 days agoOn Monday, Oppenheimer adjusted its outlook on Relay Therapeutics (NASDAQ:RLAY) shares, a...